Effect of BRAF V600E mutation on tumor response of anti-EGFR monoclonal antibodies for first-line metastatic colorectal cancer treatment: a meta-analysis of randomized studies

By Cui Dandan   Cao Dan   Yang Yu   Qiu Meng   Huang Ying   Yi Cheng  

Molecular Biology Reports, Vol. 41, Iss. 3, 2014-03 ,pp. : 1291-1298

Springer Publishing Company

Access to resources Recommend Favorite

KRAS, BRAF, EGFR and HER2 gene status in a Spanish population of colorectal cancer

By Herreros-Villanueva Marta   Rodrigo Maximiliano   Claver Manuel   Muñiz Pilar   Lastra Enrique   García-Girón Carlos   Coma del Corral Maria  

Molecular Biology Reports, Vol. 38, Iss. 2, 2011-02 ,pp. : 1315-1320

Springer Publishing Company

Access to resources Recommend Favorite

PIK3CA mutations in KRAS and BRAF wild type colorectal cancer patients. A study of Spanish population

By Herreros-Villanueva Marta   Gomez-Manero Noemí   Muñiz Pilar   García-Girón Carlos   Coma del Corral Maria  

Molecular Biology Reports, Vol. 38, Iss. 2, 2011-02 ,pp. : 1347-1351

Springer Publishing Company

Access to resources Recommend Favorite

The developing trend of monoclonal antibodies in the treatment of colorectal cancer

By Elfiky Aymen A   Saif Muhammad W  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 871-883

Informa Healthcare

Access to resources Recommend Favorite

TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls

By Liao Ru-Yan   Mao Chen   Qiu Li-Xin   Ding Hong   Chen Qing   Pan Hai-Feng  

Molecular Biology Reports, Vol. 37, Iss. 7, 2010-10 ,pp. : 3227-3232

Springer Publishing Company

Access to resources Recommend Favorite